ETHZilla Corporation, formerly known as 180 Life Sciences Corp., reported significant financial developments in its latest 10-Q filing for the quarter ending September 30, 2025. The company generated revenue of $4.1 million during the third quarter, marking a substantial increase from zero revenue in the same period last year. However, the company also reported a net loss of $216.7 million, a sharp rise from a loss of $836,720 in the prior year, primarily driven by increased operating expenses and losses from discontinued operations.
The company's operating expenses surged to $224.6 million in the third quarter, compared to $596,172 in the same quarter of 2024. This increase was largely attributed to stock-based compensation expenses related to the issuance of options and warrants, which accounted for approximately $208 million of the total. Other contributing factors included adjustments in the fair value of convertible debt, increased director fees, and higher legal and insurance costs. The loss from operations for the quarter was $220.5 million, compared to a loss of $596,172 in the previous year.
In terms of strategic developments, ETHZilla has shifted its focus away from its pharmaceutical research operations and the Gaming Technology Platform, classifying these as discontinued operations. This strategic pivot aligns with the company's new emphasis on digital asset management and decentralized finance (DeFi) initiatives. The company has also engaged in significant fundraising activities, including the issuance of convertible notes totaling $516.25 million, which have bolstered its cash reserves to approximately $558.9 million as of September 30, 2025.
Operationally, ETHZilla has made strides in its digital asset strategy, with over 70% of its Ethereum (ETH) treasury deployed across staking, lending, and other DeFi protocols. The company has entered into various agreements to enhance its treasury management, including partnerships with custodians and asset managers to optimize returns on its ETH holdings. The company’s employee headcount has also increased, reflecting its expansion into new operational areas.
Looking ahead, ETHZilla's management has expressed confidence in its ability to meet financial obligations over the next 12 months, alleviating previous concerns about its going concern status. The company plans to continue its focus on increasing its ETH position and generating revenue through its treasury strategy, although it acknowledges the inherent risks associated with the volatile digital asset market. The outlook remains contingent on the successful execution of its strategic initiatives and the evolving regulatory landscape surrounding digital assets.
About 180 Life Sciences Corp.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.